Here is one study looking at bone marrow from AML patients. http://www.ncbi.nlm.nih.gov/pubmed/19710504 That thought has actually crossed my mind and I was wondering if GSK was deliberately being selective in the cancer indications they try but I don't have the science background to even make an educated guess :-).